# Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects

> **NCT04285554** · NA · COMPLETED · sponsor: **Metavention** · enrollment: 15 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** iRF System Hepatic Denervation

## Key facts

- **NCT ID:** NCT04285554
- **Lead sponsor:** Metavention
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-28
- **Primary completion:** 2022-03-02
- **Final completion:** 2022-12-19
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04285554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04285554, "Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04285554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*